These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative. Hirai K, Aoyama H, Hosaka M, Oomori Y, Niwata Y, Suzue S, Irikura T. Antimicrob Agents Chemother; 1986 Jun; 29(6):1059-66. PubMed ID: 2942103 [Abstract] [Full Text] [Related]
7. In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients. Rolston K, Ho DH, LeBlanc B, Bodey GP. Chemotherapy; 1988 Jun; 34(6):448-54. PubMed ID: 3149568 [Abstract] [Full Text] [Related]
14. A multicenter comparative study of the in vitro activity of fleroxacin and other antimicrobial agents. Markowitz SM, Williams DS, Hanna CB, Parker JL, Pierce MA, Steele JC. Chemotherapy; 1995 Jun; 41(6):477-86. PubMed ID: 8529440 [Abstract] [Full Text] [Related]
17. Antibacterial activity of ofloxacin and its mode of action. Sato K, Inoue Y, Fujii T, Aoyama H, Mitsuhashi S. Infection; 1986 Jun; 14 Suppl 4():S226-30. PubMed ID: 3028966 [Abstract] [Full Text] [Related]
19. In vitro and in vivo activities of QA-241, a new tricyclic quinolone derivative. Asahara M, Tsuji A, Goto S, Masuda K, Kiuchi A. Antimicrob Agents Chemother; 1989 Aug; 33(8):1144-52. PubMed ID: 2679369 [Abstract] [Full Text] [Related]